Literature DB >> 8819531

Differences in beta 3-adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs.

Y T Shen1, P Cervoni, T Claus, S F Vatner.   

Abstract

The goal of our study was to compare the effects of two beta 3-adrenergic receptor agonists, i.e., BRL37344 (BRL) and CL316243 (CL), in conscious dogs, rats and nonhuman primates, instrumented with aortic and atrial catheters, ascending aortic flow probes and left ventricular (LV) pressure gauges. In conscious dogs, CL, 10 micrograms/kg, i.v., reduced, P < .05, mean arterial pressure by 8 +/- 4% and total peripheral resistance by 51 +/- 4% and increased, P < .05, LV dP/dt by 79 +/- 10% and heart rate by 88 +/- 8%. These responses were similar to those induced by BRL, 8.3 micrograms/kg, i.v. After autonomic blockade (beta 1/beta 2-adrenergic, cholinergic and ganglionic), CL still reduced total peripheral resistance by 49 +/- 4%, and increased LV dP/dt by 21 +/- 4%, without an effect on heart rate. In conscious rats, 10 times the dose of CL 100 micrograms/kg, i.v., reduced, P < .05, total peripheral resistance by 18 +/- 4%, without major effects on LV dP/dt and heart rate. BRL, 83 micrograms/kg i.v., reduced total peripheral resistance similarly by 31 +/- 3%, and increased heart rate (25 +/- 3%) and LV dP/dt (27 +/- 5%) more, P < .05. In conscious monkeys and baboons, CL, 100 micrograms/kg, i.v., did not induce significant effects, whereas BRL, 83 micrograms/kg, i.v., increased heart rate (36 +/- 6%), LV dP/dt (85 +/- 9%) and decreased total peripheral resistance (30 +/- 2%). After beta 1/beta 2-adrenergic receptor blockade in rats and primates, there were almost no differences between BRL and CL, i.e., in primates there were almost no significant cardiovascular effects with either compound. Both CL and BRL increased circulating free fatty acids in the dog, but not in the baboon. Thus, CL appears to be a more specific beta 3-adrenergic receptor agonist than BRL. More importantly, beta 3-adrenergic receptor stimulation was most profound in dogs, where even a direct effect on LV contractility was identified, was diminished but still significant in rats, and essentially absent in primates.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8819531

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  19 in total

Review 1.  The beta 3-adrenergic system and beta 3-adrenergic agonists.

Authors:  J R Arch
Journal:  Rev Endocr Metab Disord       Date:  2001-10       Impact factor: 6.514

2.  beta(3)-adrenoceptor deficiency blocks nitric oxide-dependent inhibition of myocardial contractility.

Authors:  P Varghese; R W Harrison; R A Lofthouse; D Georgakopoulos; D E Berkowitz; J M Hare
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

3.  Direct demonstration of beta1- and evidence against beta2- and beta3-adrenoceptors, in smooth muscle cells of rat small mesenteric arteries.

Authors:  Ana M Briones; Craig J Daly; Francesc Jimenez-Altayo; Sonia Martinez-Revelles; Jose M Gonzalez; John C McGrath; Elisabet Vila
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

Review 4.  Cardiac β3 -adrenoceptors-A role in human pathophysiology?

Authors:  Ebru Arioglu-Inan; Gizem Kayki-Mutlu; Martin C Michel
Journal:  Br J Pharmacol       Date:  2019-04-22       Impact factor: 8.739

Review 5.  Why So Few New Cardiovascular Drugs Translate to the Clinics.

Authors:  Stephen F Vatner
Journal:  Circ Res       Date:  2016-09-02       Impact factor: 17.367

6.  Comparison of the alpha-adrenoceptor-mediated effects of beta3-adrenoceptor ligands in rat pulmonary artery.

Authors:  Véronique Leblais; Fabrice Pourageaud; M Dolores Ivorra; Roger Marthan; Bernard Muller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-07-13       Impact factor: 3.000

7.  Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta.

Authors:  J N Trochu; V Leblais; Y Rautureau; F Bévérelli; H Le Marec; A Berdeaux; C Gauthier
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 8.  Beta 3-adrenoreceptor regulation of nitric oxide in the cardiovascular system.

Authors:  An L Moens; Ronghua Yang; Vabren L Watts; Lili A Barouch
Journal:  J Mol Cell Cardiol       Date:  2010-02-23       Impact factor: 5.000

9.  Protein kinase-dependent oxidative regulation of the cardiac Na+-K+ pump: evidence from in vivo and in vitro modulation of cell signalling.

Authors:  Keyvan Karimi Galougahi; Chia-Chi Liu; Alvaro Garcia; Natasha A S Fry; Elisha J Hamilton; Helge H Rasmussen; Gemma A Figtree
Journal:  J Physiol       Date:  2013-04-15       Impact factor: 5.182

10.  Atypical beta-adrenoceptors, different from beta 3-adrenoceptors and probably from the low-affinity state of beta 1-adrenoceptors, relax the rat isolated mesenteric artery.

Authors:  Hanna Kozłowska; Urszula Szymska; Eberhard Schlicker; Barbara Malinowska
Journal:  Br J Pharmacol       Date:  2003-08-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.